BS, University of Michigan, Ann Arbor
MD, Wayne State University School of Medicine
Residency, Ann & Robert H. Lurie Children’s Hospital of Chicago/Northwestern University Feinberg School of Medicine
Fellowship, Ann & Robert H. Lurie Children’s Hospital of Chicago/Northwestern University Feinberg School of Medicine
MSPH, University of IL at Chicago
Pediatric infectious diseases, antibiotic resistance, endocarditis, gram-negative bacterial infections, kawasaki disease, meningitis, osteomyelitis, pneumonia
Research Areas: The Clinical and Molecular Epidemiology of Multi-Drug Resistant Enterobacteriaceae Infections in Children
Latania Logan, MD, MSPH is the Chief of Pediatric Infectious Diseases at Rush University Medical Center, and a professor of pediatrics at Rush Medical College. She additionally serves as the Infection Control Officer for Rush University Children’s Hospital. Logan’s federally funded research studies the clinical and molecular epidemiology of multi-drug resistant Enterobacteriaceae infections in children, and this work is supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH). Logan serves as the Pediatrician on the Chicago Prevention and Intervention Epi-Center branch of the Centers for Disease Control and Prevention Epicenters Program, is a member of several national committees and journal editorial boards, is an ad hoc grant reviewer for the National Institutes of Health, Center for Scientific Review, and is the volunteer medical director of a Social Service Agency in Chicago.
5K08AI112506-02: “The Epidemiology of Multi-Drug Resistant Enterobacteriaceae Infections in Children”, PI
HHSN275201300003C: “International Maternal Pediatric Adolescent AIDS Clinical Trials Group”, Co PI
5R18HS021636-04: “Defining Ventilator-Associated Complications in Pediatrics”, Co Investigator, Site PI
5U54CK000161/CK/NCEZID: “Chicago Prevention and Intervention Epi-Center (Chicago PIE)”, Co Investigator
The Children’s Foundation: “Colonization and Infection in Children with Multi-Drug Resistant Gram-Negative Bacteria”, PI
“Epidemiology and Impact of Antimicrobial Resistance in Gram-negative bacteria”. Antibiotic Resistance: Burden, Implications, and Strategies to Fight Back Symposium. Pediatric Academic Societies 2018, Toronto, CA. May 5-8, 2018.
“Strategies to Prevent Carbapenem-resistant Enterobacteriaceae (CRE) in Children; Adult Size Fits All?” Society for Healthcare Epidemiology of America (SHEA) Annual Spring Meeting, Boston, MA, April 24-26, 2019.
“Old Foes, Emerging Threats: Multi-drug resistant Gram-Negative Bacterial Infections in Children.” Case Western Reserve University/VA Cleveland Middleton Symposium, Cleveland, OH, May 18, 2018.
“Resistance Determinants and Factors Associated with Multi-Drug Resistant Enterobacteriaceae in Children.” Antimicrobial Resistance Symposium. University of Buffalo Global Health Equity Community of Excellence, Buffalo, NY. May 3-4, 2018.
“The Growing Threat of Multi-drug resistant Gram-Negative Bacterial Infections in Children.” University of Buffalo Pediatric Grand Rounds, Buffalo, NY, May 4, 2018.
“MDRO Transmission in the NICU.” Session: I’m here to see the baby. Society for Healthcare Epidemiology of America (SHEA) Annual Spring Meeting, Portland, OR, April 18-20, 2018
“Pediatric Challenges in Infection Prevention.” Challenging Cases in Infection Prevention. Society for Healthcare Epidemiology of America (SHEA) Annual Spring Meeting 2018, Portland, OR, April 18-20, 2018.
“Controversies in Empiric and Definitive Treatment of ESBL Infections”. Meet the Professor Session, IDWeek 2017, San Diego CA, October 4-8, 2017.
“Water remediation strategies for gram-negative bacteria in hospital water systems.” Challenging Cases in Infection Prevention. Society for Healthcare Epidemiology of America (SHEA) Annual Spring Meeting 2017, St Louis, MO, March 29-31, 2017.